Chondrocyte ferroptosis facilitates the advancement of OA, as shown by both in vivo and in vitro studies [88]
AOD-9604 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use
The GHK peptide boosts immune function, protects the central nervous system, and reduces the risk of neurological diseases
Quality control concerns Most sublingual peptide formulations come from compounding pharmacies rather than FDA-approved manufacturers
The timeframe of the search extended up to July 2025, ensuring incorporation of the most recent evidence
Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease